Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Braxia Scientific Corp > OTC Short Selling
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(262)
•••
Post by sollmgon Nov 06, 2021 7:55pm
175 Views
Post# 34096578

OTC Short Selling

OTC Short Selling
Historical Short Volume Data for BRAXF
Date Close High Low Volume Short Volume % of Vol Shorted
Nov 05 NA NA NA 214,876 157,377 73.24
Nov 04 NA NA NA 360,829 128,616 35.64
Nov 03 NA NA NA 197,421 122,698 62.15
Nov 02 NA NA NA 306,797 149,705 48.80
Nov 01 NA NA NA 131,497 60,941 46.34
Oct 29 NA NA NA 33,438 6,493 19.42
Oct 28 NA NA NA 248,808 68,798 27.65
Oct 27 NA NA NA 204,497 77,521 37.91
Oct 26 NA NA NA 161,820 90,326 55.82
Oct 25 NA NA NA 428,038 208,915 48.81
Oct 22 NA NA NA 299,123 104,787 35.03
Oct 21 NA NA NA 216,581 64,159 29.62
Oct 20 NA NA NA 918,584 481,086 52.37
Oct 19 NA NA NA 269,909 138,968 51.49
Oct 18 NA NA NA 246,669 92,840 37.64
Oct 15 NA NA NA 200,060 105,156 52.56
Oct 14 NA NA NA 297,814 110,323 37.04
Oct 13 NA NA NA 394,523 163,923 41.55
Oct 12 NA NA NA 132,030 52,232 39.56
Oct 11 NA NA NA 118,691 54,296 45.75
Oct 08 NA NA NA 137,830 52,545 38.12

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities